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A simplified method for the separation of a kirromycin-sensitive mfB-encoded elongation factor Tu (EF-TuBs) from a kirromycin-resistant tufa 
product (EF-TuAr) was obtained by exploiting the specific increase of positive charges induced by the antibiotic, resulting in a retarded elution 
of kirromycin-bound EF-TuBs on ionic chromatography. The kirromycin-free EF-TuBs is active in poly(Phe) synthesis and shows similar properties 
to EF-TuAsBs. As expected for these two distinct species, the dissociation of the EF-TuArBs.GTP complex in the presence of kirromycin shows 
a biphasic curve; in contrast, a monophasic GTP dissociation rate was found for a combination of two mutated EF-Tu species. EF-TuArBo. 
revealing the existence of intermolecular interactions. These observations prove for the first time the existence of cooperative phenomena between 
EF-Tu species in vitro, as suggested earlier by in vivo experiments. 
Protein synthesis: Elongation factor Tu; Kirromycin 
1. INTRODUCTION 
EF-Tu is the only GTP binding protein, together with 
Ha-ras p21, with known three-dimensional structure [1- 
4] and one of the best characterized members of this 
class of proteins [5-8]. It has been the object of intensive 
mutagenesis by diverse procedures (for references, ee 
[9]). The production and isolation of mutated EF-Tu 
species from E. coli in sufficient amounts for biochemi- 
cal and physico-chemicai analysis have been hampered 
by the presence of large amounts (5-10% of the total 
cellular proteins) of viable, chromosomal tufgene pro- 
duct essential for cell growth. To overcome this crucial 
problem, a few years ago a procedure was developed to 
separate two EF-Tu species by exploiting the differences 
in affinity for the antibiotic kirromycin and the com- 
petition between EF-Ts and kirromycin for binding to 
EF-Tu [10]. In this method a mixture of kirromycin- 
resistant and kirromycin-sensitive EF-Tu species, re- 
spectively encoded by tufa (EF-TuAr) and tt(fB (EF- 
TuBe) both in complex with EF-Ts, was incubated with 
kirromycin. The resulting EF-TuAr.EF-Ts and EF- 
TuBo.kirromycin eluted as 2 separate peaks on ionic 
chromatography, the complex of EF-TuAr with EF-Ts 
emerging at much lower salt concentration. This 
method was also succesfully applied for the separation 
of a mutated plasmid-borne EF-Tu from cells harbour- 
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ing only one chromosomal tuf gene encoding an EF- 
TuAr with low affinity for the antibiotic [I 1]. 
In this work we show that similar results can be 
obtained by adding the antibiotic to a mixture of two 
EF-Tu.GDP species with different affinities to the anti- 
biotic, even in the absence f EF-Ts, as a result of the 
specific conformational modifications induced by the 
antibiotic, affecting the net charge of EF-Tu. With this 
modified method we have separated EF-TuBs from EF- 
TuAr and compared for the first time the properties of 
the former with wild-type EF-Tu (EF-TuAsBs). In the 
course of this study, by measuring the dissociation rates 
of the GTP complexes of EF-TuAsBs, EF-TuArBs and 
EF-TuArBo in the presence and absence of the antibio- 
tic, we observed that EF-TuArBo displays in vitro 
cooperative phenomena, differently from EF-TuArBs. 
This striking property is discussed in the context of 
several observations from other laboratories supporting 
the possibility of cooperative phenomena between EF- 
Tu mutants in vivo [12-15]. 
2. MATERIALS AND METHODS 
The mixture of kirromycin-resistant and kirrornycin-sensitive EF- 
Tu (EF-TuArBs) was extracted by sonication from strain PM816, an 
E. coli K I2 strain (obtained from Dr L, Bosch. University of Leiden) 
harbourlng a tufA gent encoding kirromycin-resistant EF-TuAr 
(=EF-TuA375T) and a tu.lB gene encoding kirromycin-sensitive EF- 
TuBs [16]. EF-TuAr and wild.type EF-Tu (EF-TuAsBs) or the com- 
bination of the mutated EF-Tu species (EF-TuArBo) were purified oil 
DEAE-Sepharose Fast Flow (Pharmacia) essentially as reported [I 7]. 
EF-TuBo (=EF-TuG222D) was isolated according to [10], Poly(U)- 
directed poly(Phe) synthesis and EF.Twnucleotide dissociation rates 
were determined as described [10.18]. Protein concentrations were 
measured by the method of Bradford [19] using bovine serum al- 
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Fig. 1. Separation of EF-TuBs.GDP.kirromycin from EF- 
TuAr.GDP. A mixture of EF-TuAr.GDP and EF-TuBs-GDP (total 
EF-Tu concentration 15/.tM) was incubated in buffer A containing 30 
mM KCI. 1 mM phenylmethylsulpbonyl fluoride and 20/.tM kirromy- 
cin for 30 rain at 4°C. The incubation mixture was applied to a DEAE 
Sepharose column (60 x 0.9 gin) and the proteins were eluted with a 
linear gradient of KCI (dashed line) in buffer A. Fractions were ana- 
lysed for GDP-binding activity (11) and for the presence of kirromycin 
by measuring the absorbance at 325 nm (...): (--) absorbance at 280 
nm. 
bumine as a standard. The standard assay buffer contained 50 mM 
Tris-HCI. pH 7.6. 60 rnM NH4CI. 7 mM MgCI z and 7 mM 2-mercap- 
toethanol. Buffer A contained 50 mM Tris-HCl. pH 7.6, 5 mM MgCI, 
and 7 mM 2-mercaptoethanol. 
3. RESULTS 
3.1. Kirromycin-bound form qf  EF-TuB.GDP is strongly 
retarded on hmic Chromatography 
Recently. we have observed that kirromycin strongly 
modifies the electrophoretic behaviour of EF-Tu, in- 
creasing the positive charge as compared to the wild- 
type [20]. This has led us to test whether the antibiotic 
alone induces aconformational transition whose charge 
alteration is sufficient to separate a mixture of two EF- 
Tu species, of which only one is sensitive to the antibio- 
tic. To this purpose we have partially purified EF-Tu 
from E. coli strain PM816, containing a mixture of 
EF-TuAr.GDP and wild-type EF-TuBsGDP. After 
sonication of the cells and a centrifugation at 30 000 × 
g for 40 min. the cell extract was applied to a DEAE- 
t~ 
0.6 
,< 
"0.3 
November  1991 
E 15 
,.... 
0 
E 
F- 
" '  10 
N 
'- 5 
e, -  
o 
0 ~ i 
0 5 10 1'5 
Time (rain) 
Fig. 2. Poly(U)-directed poly(Phe) synthesis by EF-TuAsBs and EF- 
TuBs. Poly(U)-directed poly(Phe) synthesis was carried out as report- 
ed in [10] with EF-TuAsBs (D) or EF-TuBs (©). 
Sepharose Fast Flow column and elated with a KCI 
gradient (50 to 250 mM) in buffer A. The isolated EF- 
Tu.GDP was more than 60% pure, and the recovery was 
at least 90%. This EF-Tu.GDP was incubated with kir- 
romycin for 30 min at 4°C, as described in the legend 
to Fig. 1. The concentration of EF-Tu and kirromycin 
was about 15/.tM and 20/gM, respectively, to avoid any 
binding of  the antibiotic to the kirromycin-resistant EF- 
Tu species. In the following DEAE-Sepharose Fast 
Flow chromatography (a gradient of 80-250 mM KCI 
in buffer A) EF-TuAr.GDP and EF-TuBs.GDP.kir- 
romycin were eluted without any overlapping as 2 in- 
dependent peaks, as a consequence of the strong 
retardation induced upon EF-TuBs.GDP by the anti- 
biotic (Fig. 1). To obtain the EF-TuBs.GDP free from 
kirromycin the usual procedure was applied, i.e. a 
prolonged dialysis in the presence of EF-Ts, exploiting 
the competition between the latter factor and the anti- 
biotic for binding to EF-Tu [10]. All the steps needed 
for the separation and isolation of EF-TuBs in its GDP- 
bound form are resumed in Table I. 
Table I 
Schematical overview of the procedure for the purification of EF-TuBs 
Purilication step Starting material 
1. DEAE Scpharose 
2. Kirrmnyein treatment + DEAE Sepharosc 
3. Dialysis in the presence or EF-Ts + DEAE 
Sepharose 
4. Incubation with excess of GDP .t. DEAE Scpharose to replace EF-Ts and to obtain EF- 
TuI3s.GDP 
Crude cell extract of strain PMSI6 
Mixture EF-TuAr GDP/EF .TuBsGDP 
EF-TuBs.kirromycin 
EF-TuBs.EF-Ts 
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Fig, 3. Effect ofkirromycin on the GTP dissociation rates ofvarious EF-Tu species, alone or in combination. Reactions were carried out as described 
[18]. Nucleotide free EF-Tu (1/a,M) and [~'-~-'P]GTP (2.5 ltM) were incubated in standard buffer at 0°C for 15 rain in the absence (t~) or presence 
(B) of kirromycin (2.5 pM). The dissociation reaction was started by the addition of 1000-fold excess of unlabeled GTP. At the indicated times, 
samples were withdrawn and filtered through nitrocellulose lilters (Sartorius 0.45 pro) which were washed twice with cold standard buffer. 
ln(c,/Co)=-k_vt were k_~ is the dissociation rate constant, co is the initial concentration of the EF-Tu.GTP complex and ct the concentration at
different times t. In panel F, the broken life represents he theoretical course of the dissociation of a mixture of EF-TuAr.GTP (dissociation half-life 
70 s) and EF-TuBo.GTP.kirromycin (dissociation half-life 75 rain). 
The isolation of EF-TuBs in homogeneous form en- 
abled us to test whether the purified tufB product, which 
differs only at its C-terminus from the tufA gene pro- 
duct (Ser instead of Gly), would display any functional 
differences from wild-type EF-Tu which is constituted 
in a 60 to 40% ratio by the tufA and tufB products [16] 
(see Fig. 1). In Fig. 2 is shown that EF-TuBs is as active 
in poly(UP)-directed poly(Phe) synthesis as EF- 
TuAsBs. Its sensitivity to kirromycin is also similar to 
that of  EF-TuAsBs (not shown). The dissociation of the 
respective complexes with GDP and GTP, parameters 
which are very sensitive to functional modifications, 
occurs with comparable half-life values (see below). 
These results strongly suggest hat the activity of EF- 
TuBs is identical to that of EF-TuAsBs and as a conse- 
quence as that of EF-TuAs. 
3.2. h2termolecular btteractions of EF. Tu 
During the isolation and characterization of tile dif- 
ferent species of EF-Tu we have met with some observa- 
tions on EF-TuArBo from strain LBE2012, that could 
only be explained by assuming the occurrence of inter- 
molecular interactions of EF-Tu and, thus, could 
support the possibility of reported cooperative phe- 
nomena in vivo ([12-15]; see also section 4). As a re. 
levant background to our in vitro experiments, one 
should remember that the interaction of EF-Tu with 
guanine nucleotides i characterized by a difference of 
2 orders of magnitude in the binding for GDP and GTP. 
The main cause for this difference is the slower dissocia. 
tion rate of GDP from EF-Tu.GDP as compared to tile 
faster dissociation rate of GTP fi'om EF-Tu.GTP. In 
the presence of kirromycin the dissociation rate of GTP 
from the EF-Tu.GTP.kirromycin complex is drastically 
reduced so that the affinity of EF-Tu for GTP becomes 
of the same order as that for GDP [18]. Fig. 3A, B and 
E illustrate this phenomenon for several kirromycin- 
sensitive EF-Tu preparations (half-life 70 s for EF. 
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Fig. 4. Effect of kirromycin on the GDP dissociation rates of EF-TuBs 
and EF-TuArBo. Reactions were carried out as described in the legend 
of Fig. 3, except hat [3H]GDP replaced [?,-3ZP]GTP. EF-Tu (1 pM, 
nucleotide free) and ["H]GDP (I pM) were incubated at 0°C for 15 
rain in standard buffer in the absence (open symbols) or presence 
(closed symbols) of 2.5/aM kirromycin. Reactions were started by the 
addition of 1000-fold excess of tm!abeled GDP. (©.O) EF-TuBs; (D.m) 
EF-TuArBo; the broken line represents he theoretical course of disso- 
ciation of an equimolar mixture of  EF-TuAr.GDP (dissociation half- 
life 50 rain) and EF-TuBo.GDP-kirromycin (dissociation half-life 15 
rain). 
TuAsBs and EF-TuBs and 51 s for EF-TuBo in the 
absence, versus 75 rain in the presence of kirromycin), 
while Fig. 3D shows that addition of the antibiotic 
hardly affects the behaviour of kirromycin-resistant 
EF-TuAr (half-life 70 versus 75 s). Taking into account 
these different GTP dissociation properties of EF- 
Tu.GTP and EF-TuGTP.kirromycin one should be 
able to reveal a heterogeneity in mixed factor prepara- 
tions containing both kirromycin-sensitive and kirro- 
mycin-resistant EF-Tu upon addition of a limiting 
amount of the antibiotic. Indeed, this applies to the 
mixture EF-TuArBs (Fig. 3C): EF-TuAr.GTP displays 
a fast dissociation (half-life 70 s), while EF- 
TuBs.GTP.kirromycin forms a stable complex (half-life 
75 rain). Most strikingly however, no trace of a fast 
component is apparent in the dissociation of EF- 
TuArBo.GTP.kirromycin; instead, one observes a mo- 
nophasic dissociation with a relatively long half-life (45 
min; Fig, 3F). which is in the range of that of kirro- 
mycin-sensitive EF-Tu. In an attempt o explain this 
phenomenon one has to assume an intermolecular inter- 
action between the 2 mutant EF-Tu species, causing an 
altered behaviour of EF-TuAr towards the antibiotic. 
We tested whether these effects occurred for the 
GDP-bound forms of EF-TuArBo. It is known, that the 
dissociation rates of EF-TuAsBs.GDP [18], EF- 
TuBo.GDP [10] or EF-TuBs.GDP (Fig. 4) are a few 
times faster in the presence of kirromycin (half-life 50 
min in the absence and 15 min in the presence of the 
antibiotic), while that of EF-TuAr.GDP is unaffected. 
As shown in Fig. 4, differently from the results obtained 
with the corresponding GTP-bound complex, kirro- 
mycin reveals heterogeneity in the dissociation rate of 
EF-TuArBo in the presence of GDP, suggesting that the 
cooperative phenomena strictly depend on the GTP- 
bound form and the presence of a specific mutation in 
EF-Tu (Gly222--->Asp). We could not test the behaviour 
of the mixture of EF-TuAs and EF-TuBo with this 
method, because these EF-Tu species are both sensitive 
to kirromycin. 
4. DISCUSSION 
The observation that binding of kirromycin to EF- 
Tu.GDP induces an alteration of the net charge of the 
factor to an extent allowing the complete separation of 
the EF-Tu.GDP.kirromycin complex from EF- 
TuAr.GDP on ionic chromatography, simplifies the 
procedure for isolating EF-Tu mutants overproduced in 
E. coli. Moreover, it shows how deeply the selective 
action of kirromycin modifies the EF-Tu.GDP con- 
formation. The advantage of using EF-Tu.GDP instead 
of EF-Tu.EF-Ts is evident. EF-Tu.GDP, which ac- 
counts for 80-90% of the total EF-Tu in the cell, can be 
easily obtained from the cell extract up to 60-80% pure 
in a one-step separation either by ionic or affinity 
chromatography. Thus the largest part of EF-Tu may 
be straigtly processed as EF-Tu.GDP complex, mark- 
edly increasing the yield of the mutated protein. We 
have succesfully applied this method not only to the 
separation of the nfB product as described in this 
paper, but also of the overproduced EF-TuC81G, a 
factor mutated in a residue located in the guanine nu- 
cleotide binding site (P.H. Anborgh and J. Jonak, un- 
published results). The characterization of EF-TuBs in 
pure form has led us to the conclusion that no func- 
tional difference xists between tile tufB gene product 
and wild-type EF-Tu, as also suggested by Vijgenboom 
[21], who separated the EF-TuBs factor using another 
method. 
Of particular interest is the observation that 2 
mutated EF-Tu species (EF-TuAr and EF-TuBo) show 
intermolecular interactions in an in vitro system, the 
kirromycin-sensitive EF-Tu being dominant over the 
kirromycin-resistant EF-Tu. Cooperative effects of 
these two EF-Tu species have already been reported in 
vivo. Vijgenboe', et al. [12] observed that the suppres- 
sion of nonsense codons requires the combined action 
of EF-TuAr and EF-TuBo, the combinations EF-TuAr 
with EF-TuBs or EF-TuAs with EF-TuB0 being in- 
effective. It~ line with this, Hughes [13] reported that in 
vivo suppression of certain termination codons in 
Sahnonella typhhnurium is much more efficient if both 
tufgene products are mutated. Strains with a mutation 
in both tufgenes are particularly active in suppressing 
- 1/+ 1 frameshifting by EF-Tu [14,15]. These reports fit 
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well with our observations in vitro and suggest hat 
intermolecular interactions in EF-Tu are related to spe- 
cific substitutions. However, one should mention that 
other authors contest he importance of EF-TuBo for 
the suppression of nonsense codons by EF-TuAr [22]. 
Nevertheless, the possibility of the participation of 2 
molecules of EF-Tu.GTP in the formation of a penta- 
meric complex with aa-tRNA [23] and the observation 
by small angle neutron scattering of the presence of 
EF-Tu dirners in solution [24] appears to extent the 
importance of intermolecular interactions also to the 
activity of wild-type EF-Tu, underlining the need for 
further studies aimed at clarifying the functional aspects 
of these phenomena. 
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